Virax Biolabs
VRAX
VRAX
3 hedge funds and large institutions have $12.5K invested in Virax Biolabs in 2024 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
3
Holders Change
-1
Holders Change %
-25%
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
$10.6K |
| 2 |
UBS Group
Zurich,
Switzerland
|
$1.85K |
Top Sellers
| 1 |
AC
Armistice Capital
New York
|
$0 |
| 2 |
VF
Virtu Financial
New York
|
$0 |
| 3 |
Wells Fargo
San Francisco,
California
|
$72 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Citadel Advisors
Miami,
Florida
| $10.6K | +$10.6K | +14,785 | New |
|
|
2
UBS Group
Zurich,
Switzerland
| $1.85K | +$1.37K | +1,910 | +287% |
|
|
3
Wells Fargo
San Francisco,
California
| $72 | -$72 | -100 | -50% |
|
|
AC
4
Armistice Capital
New York
| – | -$178K | -121,999 | Closed |
|
|
VF
5
Virtu Financial
New York
| – | -$16K | -10,644 | Closed |
|